Overview

DDI Between BI Empagliflozin (10773) and Verapamil

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Relative bioavailability of BI 10773 given alone and together with verapamil
Phase:
Phase 1
Details
Lead Sponsor:
Boehringer Ingelheim
Treatments:
Empagliflozin
Verapamil